TITLE

Why we should lead a heart-healthy life

AUTHOR(S)
Hummerston, Gemma
PUB. DATE
August 2014
SOURCE
British Journal of Cardiac Nursing;Aug2014, Vol. 9 Issue 8, p369
SOURCE TYPE
Academic Journal
DOC. TYPE
Editorial
ABSTRACT
The author emphasizes the importance of leading a healthy life to help reduce the risk of cardiovascular disease (CVD). Topics covered by the author include the other aspects of leading a heart-healthy life aside from exercise, the source of the controversy around recommendations from the National Institute ofHealth and Care Excellence (NICE) for people at low risk of CVD to be prescribed statins and the difficulty health professionals are having in convincing people to make life changes.
ACCESSION #
97330533

 

Related Articles

  • The Most Important Thing You Can Do for Your Heart.  // Tufts University Health & Nutrition Letter;Sep2014, Vol. 32 Issue 7, p1 

    The article discusses research published in the periodical "British Journal of Sports Medicine" that examined the role of physical activity in reducing heart disease in women. Topics include the risk contributed by lack of physical activity, smoking, obesity, and high blood pressure for heart...

  • CVD Masterclass: A lifetime approach to the prevention of cardiovascular disease. Haws, Joanne M. // Practice Nurse;9/19/2014, Vol. 44 Issue 9, p26 

    The article discusses an approach by the Joint British Societies for reducing the burden of cardiovascular disease (CVD) in individuals by promoting a better understanding of risk, improving uptake of lifestyle improvements and improving uptake of preventive therapies. Topics discussed include...

  • Prevention and rehabilitation: Going for gold. Stuart-Jones, Vicqui // British Journal of Cardiac Nursing;Aug2012, Vol. 7 Issue 8, p400 

    The article discusses the British Cardiovascular Society Affiliate's Day which was based on the theme of 'giving patients a sporting chance.' Several sessions of the programme included topics such as parallels between cardiopulmonary case management and an elite endurance athlete, assessment of...

  • Prevention of Non-Communicable Diseases: What can be done? Merat, Shahin; Malekzadeh, Reza // Archives of Iranian Medicine (AIM);Mar2013, Vol. 16 Issue 3, p136 

    An introduction is presented in which the editor discusses various reports within the issue on cardiovascular disease (CVD), non-communicable disease (NCD), and community health-care workers (CHW).

  • "Real world" CVD advice.  // Clinical Advisor;Mar2011, Vol. 14 Issue 3, p32 

    The article offers information on the 2011 guidelines from the American Heart Association for the prevention of cardiovascular disease (CVD) in women. It mentions that the updated guidelines encourage physicians to consider patient diversity in managing the risk of CVD. It also notes that the...

  • Lipid modification and prevention of CVD: lifestyle recommendations and statin treatment. Linden, Belinda // British Journal of Cardiac Nursing;Oct2014, Vol. 9 Issue 10, p476 

    The article presents an overview of the latest guidance from the National Institute for Health and Care Excellence (NICE) with respect to lifestyle modification and statin treatment for the reduction of cholesterol levels. Topics discussed include NICE's recommendation for people at high risk of...

  • Perceived social support for diet and exercise among persons with serious mental illness enrolled in a healthy lifestyle intervention. Aschbrenner, Kelly A.; Mueser, Kim T.; Bartels, Stephen J.; Pratt, Sarah I. // Psychiatric Rehabilitation Journal;Jun2013, Vol. 36 Issue 2, p65 

    Objective: There is a lack of research on social support for health behavior change among persons with serious mental illness who face disproportionate morbidity and premature death due to cardiovascular disease. This study examined social contact and the demographic, health and clinical...

  • Just 10 minutes a day will help the heart. KNAPTON, MIKE // Independent Nurse;2/16/2015, p16 

    No abstract available.

  • Lipid management: maximising reduction of cardiac risk. Webb, J.; Gonna, H.; Ray, K. K. // Clinical Medicine;Dec2013, Vol. 13 Issue 6, p618 

    The article discusses the use of lipid modification therapies (LMTs) for the primary and secondary prevention of cardiovascular disease (CVD), particularly coronary artery disease (CAD) in Great Britain as of December 2013. Topics discussed include log linear relationship between total...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics